Evidence map›Paper›PMID 35717193›Full record

Trial reportBMC health services research2022

Defining optimal implementation packages for delivering community-wide mass drug administration for soil-transmitted helminths with high coverage.

Marie-Claire Gwayi-Chore, Kumudha Aruldas, Euripide Avokpaho, Chawanangwa Maherebe Chirambo, Saravanakumar Puthupalayam Kaliappan, Parfait Houngbégnon, Comlanvi Innocent Togbevi, Félicien Chabi, Providence Nindi, James Simwanza and 8 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 4 countries.

Marie-Claire Gwayi-ChoreDepartment of Global Health, University of Washington, Seattle, USA. cgwayi@uw.edu.ORCID http://orcid.org/0000-0002-2003-422X
Kumudha AruldasThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
Euripide AvokpahoInstitut de Recherche Clinique du Benin, Abomey-Calavi, Benin.
Chawanangwa Maherebe ChiramboBlantyre Institute for Community Outreach (BICO), Lions Sight First Eye Hospital, Blantyre, Malawi.
Saravanakumar Puthupalayam KaliappanThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
Parfait HoungbégnonInstitut de Recherche Clinique du Benin, Abomey-Calavi, Benin.
Comlanvi Innocent TogbeviInstitut de Recherche Clinique du Benin, Abomey-Calavi, Benin.
Félicien ChabiInstitut de Recherche Clinique du Benin, Abomey-Calavi, Benin.
Providence NindiBlantyre Institute for Community Outreach (BICO), Lions Sight First Eye Hospital, Blantyre, Malawi.
James SimwanzaBlantyre Institute for Community Outreach (BICO), Lions Sight First Eye Hospital, Blantyre, Malawi.
Jabaselvi JohnsonThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
Edward J MiechCenter for Health Services Research, Regenstrief Institute, Indianapolis, USA.
Khumbo KaluaBlantyre Institute for Community Outreach (BICO), Lions Sight First Eye Hospital, Blantyre, Malawi.
Moudachirou IbikounléInstitut de Recherche Clinique du Benin, Abomey-Calavi, Benin.
Sitara S R AjjampurThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
Bryan J WeinerDepartment of Global Health, University of Washington, Seattle, USA.
Judd L WalsonDepartment of Global Health, University of Washington, Seattle, USA.
Arianna Rubin MeansDepartment of Global Health, University of Washington, Seattle, USA.
Christian Medical College, Vellore · INUniversity of Washington · USBlantyre Institute for Community Ophthalmology · MWKamuzu Central Hospital · MWRegenstrief Institute · USUniversité d'Abomey-Calavi · BJ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent evidence suggests that community-wide mass drug administration (MDA) may interrupt the transmission of soil-transmitted helminths (STH), a group of intestinal worms that infect 1.5 billion individuals globally. Although current operational guidelines provide best practices for effective MDA delivery, they do not describe which activities are most essential for achieving high coverage or how they work together to produce effective intervention delivery. We aimed to identify the various packages of influential intervention delivery activities that result in high coverage of community-wide MDA for STH in Benin, India, and Malawi.

methodsWe applied coincidence analysis (CNA), a novel cross-case analytical method, to process mapping data as part of the implementation science research of the DeWorm3 Project, a Hybrid Type 1 cluster randomized controlled trial assessing the feasibility of interrupting the transmission of STH using bi-annual community-wide MDA in Benin, India, and Malawi. Our analysis aimed to identify any necessary and/or sufficient combinations of intervention delivery activities (i.e., implementation pathways) that resulted in high MDA coverage. Activities were related to drug supply chain, implementer training, community sensitization strategy, intervention duration, and implementation context. We used pooled implementation data from three sites and six intervention rounds, with study clusters serving as analytical cases (N = 360). Secondary analyses assessed differences in pathways across sites and over intervention rounds.

resultsAcross all three sites and six intervention rounds, efficient duration of MDA delivery (within ten days) singularly emerged as a common and fundamental component for achieving high MDA coverage when combined with other particular activities, including a conducive implementation context, early arrival of albendazole before the planned start of MDA, or a flexible community sensitization strategy. No individual activity proved sufficient by itself for producing high MDA coverage. We observed four possible overall models that could explain effective MDA delivery strategies, all which included efficient duration of MDA delivery as an integral component.

conclusionEfficient duration of MDA delivery uniquely stood out as a highly influential implementation activity for producing high coverage of community-wide MDA for STH. Effective MDA delivery can be achieved with flexible implementation strategies that include various combinations of influential intervention components.

Indexed as

AnthelminticsHelminthiasisHelminthsAnimalsHumansMass Drug AdministrationPrevalenceSoilAnthelminticsSoilCoincidence analysisConfigurational comparative methodsGlobal health implementation scienceNeglected tropical disease

Identifiers

PMID35717193
PMCPMC9206125
OpenAlexW4283076571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.